ConductScience.org, home

Trial · NCT07892898

A Prospective Comparative Clinical Trial of Postoperative Delirium Incidence in Open Versus Laparoscopic Nephrectomy

NCT07892898, Not applicable, Completed, Alexandria University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Prospective Comparative Clinical Trial of Postoperative Delirium Incidence in Open Versus Laparoscopic Nephrectomy. Trials, record NCT07892898. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892898

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Prospective Comparative Clinical Trial of Postoperative Delirium Incidence in Open Versus Laparoscopic Nephrectomy
NCT number
NCT07892898
Status
Completed
Phases
Not applicable
Enrollment
134 participants, actual
Lead sponsor
Alexandria University
Conditions
Postoperative Delirium (POD) After Nephrectomy
Interventions
Open Nephrectomy, Laparoscopic Nephrectomy
First posted
2026-10-23
Last updated
2026-11-03

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Postoperative DeliriumOnce daily on Postoperative Days (POD) 1, 2, and 3.
The presence or absence of delirium will be assessed using the Confusion Assessment Method (CAM). For patients who screen positive via CAM, delirium severity will be graded using the Delirium Index (DI). The DI scores 7 domains from 0 (absent) to 3 (severe), with a total score range of 0 to 21 (higher scores indicate worse severity.
SecondaryPostoperative Pain Intensity at Rest and During MovementPostoperative Days (POD) 1, 2, and 3.Evaluated using the Visual Analog Scale (VAS), ranging from 0 cm (no pain) to 10 cm (worst possible pain
SecondaryCumulative Postoperative Analgesic ConsumptionPostoperative Days (POD) 1, 2, and 3.Total intravenous morphine consumption (mg) via the Patient-Controlled Analgesia (PCA) device and total rescue IV morphine boluses (0.05 mg/kg) administered for breakthrough pain (VAS \> 4).
SecondaryPostoperative Functional Recovery MilestonesFrom end of surgery up to hospital discharge (monitored daily, up to an estimated 14 days).Time to first time sitting out of bed (hours), time to first ward ambulation (hours), time to first passage of flatus (hours), and overall length of hospital stay (days).
SecondaryIntraoperative Hemodynamic and Anesthetic Depth ParametersBaseline (Pre-induction, T1), 45 minutes intraoperatively (T2), 90 minutes intraoperatively (T3), and 10 minutes before the end of surgery (T4).Mean Arterial Pressure (MAP in mmHg), Heart Rate (HR in bpm), Bispectral Index (BIS value), Oxygen Saturation (SpO2 percentage), and Arterial Blood Gas measurements (pH, PaO2 in mmHg, PaCO2 in mmHg).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07892898

GET https://conductscience.org/api/trials/v1/NCT07892898/registered